News & Updates

Show Multimedia Only

Gefurulimab for AChR-Ab–positive gMG succeeds in phase III trial

17 Aug 2026 by

Gefurulimab, a novel bispecific nanobody that targets complement factor 5 (C5) delivers rapid and sustained clinical benefit in patients with anti–acetylcholine receptor antibody–positive (AChR-Ab+) generalized myasthenia gravis (gMG), as shown in the phase III PREVAIL trial.

Gefurulimab for AChR-Ab–positive gMG succeeds in phase III trial

17 Aug 2026

Tim-3 blockade controls tumour growth in metabolic liver cancer

17 Aug 2026

In patients with steatohepatitis-related hepatocellular carcinoma (HCC), Tim-3 plays a key role in regulating dendritic cell (DC) ferroptosis, with its expression predicting poor prognosis, suggests a study.

Tim-3 blockade controls tumour growth in metabolic liver cancer

17 Aug 2026

Second-line adagrasib plus cetuximab falls short of extending survival in KRAS G12C-mutated mCRC

17 Aug 2026 by

Second-line treatment with adagrasib plus cetuximab demonstrates manageable safety but results in no statistically significant improvement in both progression-free (PFS) and overall survival (OS) in previously treated patients with KRAS G12C-mutated metastatic colorectal cancer (mCRC) compared with chemotherapy, results of the KRYSTAL-10 trial have shown.

Second-line adagrasib plus cetuximab falls short of extending survival in KRAS G12C-mutated mCRC

17 Aug 2026

Nicotinamide supplementation boosts human-milk vitamin B3 concentrations

17 Aug 2026

Lactating women with no nicotinamide supplementation tend to have human-milk total vitamin B3 concentrations below the fifth percentile reference limit, a Tanzania study has found.

Nicotinamide supplementation boosts human-milk vitamin B3 concentrations

17 Aug 2026

Kids with CAH exhibit distinct, age-dependent developmental deficits

17 Aug 2026 by

In a cross-sectional study, children with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency show distinct developmental challenges at different ages.

Kids with CAH exhibit distinct, age-dependent developmental deficits

17 Aug 2026

Navigating the safety profile of tramadol-paracetamol in chronic pain

17 Aug 2026

Pain is multifaceted and may involve multiple mechanisms, supporting the use of analgesics with complementary pharmacological profiles. Combining tramadol and paracetamol may produce additive or synergistic analgesic effects while allowing lower doses of individual agents, potentially improving tolerability and reducing adverse effects.

Navigating the safety profile of tramadol-paracetamol in chronic pain

17 Aug 2026

Lower risk of asthma exacerbation with GLP-1 RA vs DPP-4i in patients with DM

17 Aug 2026 by

A retrospective cohort study conducted in Hong Kong among adults with co-existing asthma and diabetes mellitus (DM) has found a lower risk of asthma exacerbation with glucagon-like peptide-1 receptor agonist (GLP-1 RA) vs dipeptidyl peptidase-4 inhibitor (DPP-4i) treatment.

Lower risk of asthma exacerbation with GLP-1 RA vs DPP-4i in patients with DM

17 Aug 2026

Tech-blended exercise a feasible strategy for improving outcomes in T2D

16 Aug 2026 by

A 12-week exercise intervention delivered via a blended modality of face-to-face, Zoom-based, and video-recorded sessions to promote adherence to physical activity among middle-aged and older adults with type 2 diabetes (T2D) in Singapore is feasible and may help improve outcomes, including cognitive performance, as shown in a mixed-methods study.

Tech-blended exercise a feasible strategy for improving outcomes in T2D

16 Aug 2026

Treatment of hypertension, hyperlipidaemia subpar among adults with CKM syndrome

16 Aug 2026

Treatment of hypertension and hyperlipidaemia among adults with cardiovascular-kidney-metabolic (CKM) syndrome remains low, according to a US study. Moreover, only a few of the treated individuals achieve blood pressure (BP) or glycaemic control.

Treatment of hypertension, hyperlipidaemia subpar among adults with CKM syndrome

16 Aug 2026

Lactobacillus-containing probiotics may boost ART success

15 Aug 2026 by

The use of Lactobacillus-containing probiotics may help improve pregnancy rates among women undergoing assisted reproductive technology (ART), according to a systematic review and meta-analysis.

Lactobacillus-containing probiotics may boost ART success

15 Aug 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Gefurulimab for AChR-Ab–positive gMG succeeds in phase III trial

Gefurulimab for AChR-Ab–positive gMG succeeds in phase III trial

Tim-3 blockade controls tumour growth in metabolic liver cancer

Tim-3 blockade controls tumour growth in metabolic liver cancer

Second-line adagrasib plus cetuximab falls short of extending survival in KRAS G12C-mutated mCRC

Second-line adagrasib plus cetuximab falls short of extending survival in KRAS G12C-mutated mCRC

Nicotinamide supplementation boosts human-milk vitamin B3 concentrations

Nicotinamide supplementation boosts human-milk vitamin B3 concentrations

Kids with CAH exhibit distinct, age-dependent developmental deficits

Kids with CAH exhibit distinct, age-dependent developmental deficits

Navigating the safety profile of tramadol-paracetamol in chronic pain

Navigating the safety profile of tramadol-paracetamol in chronic pain

Lower risk of asthma exacerbation with GLP-1 RA vs DPP-4i in patients with DM

Lower risk of asthma exacerbation with GLP-1 RA vs DPP-4i in patients with DM

Tech-blended exercise a feasible strategy for improving outcomes in T2D

Tech-blended exercise a feasible strategy for improving outcomes in T2D

Treatment of hypertension, hyperlipidaemia subpar among adults with CKM syndrome

Treatment of hypertension, hyperlipidaemia subpar among adults with CKM syndrome

Lactobacillus-containing probiotics may boost ART success

Lactobacillus-containing probiotics may boost ART success